[High-dose chemotherapy with bone marrow transplantation in recurrent or refractory NHL].
Torello
E
E
Unidad de Trasplante de Medula Osea, Hospital Privado de Oncología, Buenos Aires, Argentina.
Koziner
B
B
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016913:Blood Component Transfusion; D001804:Blood Transfusion, Autologous; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation / Q000379:methods / Q000401:mortality; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004351:Drug Resistance; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D015337:Multicenter Studies as Topic; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D012189:Retrospective Studies; D016896:Treatment Outcome
D016298:Hematopoietic Cell Growth Factors
Altas dosis de quimioterapia (AD-QT) con trasplante de medula ósea (TMO) en LNH recaídos o refractarios.